In the Q4 2020 Investor Letter, the fund highlighted a few stocks and DexCom Inc (NASDAQ: DXCM ) is one of them. DexCom Inc (NASDAQ: DXCM ) is a company that develops, manufactures, and distributes continuous glucose monitoring systems for diabetes management. In the last three months, DexCom Inc (NASDAQ: DXCM ) stock gained 0.1% and on March 23rd it had a closing price of $364.17. Here is what the fund said: